跳至主要内容
临床试验/ACTRN12622000914763
ACTRN12622000914763招募中未知

Orally Administered Faecal Microbial Transplantation in the Management of Immune Checkpoint Inhibitor Associated Colitis - A randomised control trial to assess safety and preliminary efficacy

St Vincent's Hospital Sydney0 个研究点目标入组 46 人开始时间: 2022年6月27日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Grade 2 or more diarrhoea (greater than 4 bowel actions more than baseline)
  • Last dose of checkpoint inhibitor within 4 months of symptom onset
  • No response to oral glucocorticoids
  • Steroid intolerant
  • Recurrence of symptoms during or following corticosteroid wean
  • Recurrent episode of immune checkpoint inhibitor colitis.

排除标准

  • -Infective colitis
  • -Inflammatory bowel disease
  • -Previous colectomy
  • -Significant medical comorbidity

研究者

发起方
St Vincent's Hospital Sydney

相似试验